GlassScriptPhysician profile
Peter M Farrugia
NPI 1003142530
$599,833.48
in general payments reported to CMS, 2019-2025
40 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,066 · 2020: $62K · 2021: $114K · 2022: $23K · 2023: $204K · 2024: $170K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $376K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000 · Travel and Lodging: $2,847 · Food and Beverage: $2,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $376,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
| Travel and Lodging | $2,847.02 |
| Food and Beverage | $2,426.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $460,960.83 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $93,417.64 | 2020-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Crosser Iq |
| Abbott Laboratories | $19,645.95 | 2019-2025 | Diamondback Peripheral, Supera, Femostop |
| Cardiovascular Systems INC. | $17,227.11 | 2019-2023 | Diamondback Peripheral |
| Esperion Therapeutics, INC. | $2,524.49 | 2020 | |
| Penumbra, INC. | $2,400.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $814.06 | 2019-2022 | |
| Philips North America LLC | $298.35 | 2019-2024 | (5050) Extended Holter |
| Medtronic Vascular, INC. | $295.61 | 2019 | |
| Boston Scientific Corporation | $261.66 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $258.05 | 2019-2022 | |
| Astellas Pharma US INC | $212.11 | 2021 | |
| Irhythm Technologies, INC. | $205.84 | 2020-2021 | |
| Recor Medical INC | $191.61 | 2025 | Paradise Ultrasound Renal Denervation System |
| Asahi Intecc USA, INC. | $142.75 | 2025 | Asahi Peripheral Vascular Wires, Asahi Coronary Wires |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Farrugia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.